Orthopedics Centre of Excellence Planned for Guy’s Hospital
|
By HospiMedica International staff writers Posted on 11 Dec 2017 |
|
Image: Guy\'s and St. Thomas\' hospital and Johnson & Johnson join forces to improve orthopedic care (Photo courtesy of Guy’s and St. Thomas’ NHS Foundation Trust).
Johnson & Johnson (JNJ; New Brunswick, NJ, USA) Managed Services and Guy's and St. Thomas' NHS Foundation Trust (London, United Kingdom) have entered into a 15-year partnership to deliver an Orthopedics Centre of Excellence.
The new partnership between JNJ Managed Services and Guy’s and St. Thomas’ NHS Foundation Trust is designed to optimize the standard of care for orthopedic patients by addressing challenges facing the NHS highlighted in two recent reports by Lord Carter and Professor Briggs, which attempt to address increasing resource challenges in the United Kingdom, partly due to changing demographics that project that by 2030, there will be around 15 million people in the United Kingdom over the age of 65.
As part of the agreement, the orthopedics center at Guy’s Hospital will be expanded and redeveloped, allowing more patients to have access to services. Plans include the development of an additional operating theatre in year one, and eight new state-of-the-art theatres by the end of year three. JNJ will also streamline the supply chain to procure devices, surgical instruments, and implants needed for orthopedic surgery. The Center of Excellence will also provide a hub for education and training, and offer a dedicated space to facilitate leading-edge research.
“The Johnson & Johnson Managed Services partnership will further increase the time that frontline clinicians can focus on patient care and enable us to identify opportunities to improve the supply chain,” said Peter Earnshaw, clinical director of surgery at Guy’s and St. Thomas’. “Through the development of new operating theatres, it will also increase capacity so that we can treat more patients more quickly and will give our clinical teams opportunities to be at the forefront of new developments in orthopedic care.”
“This latest collaboration is testament to our ongoing commitment to Guy’s and St. Thomas’ NHS Foundation Trust, and our commitment to join forces with health care systems to help them address their most pressing challenges,” said Michelle Brennan, Company Group Chair of JNJ Medical Devices Europe, Middle East, and Africa.
Related Links:
Johnson & Johnson
Guy's and St. Thomas' NHS Foundation Trust
The new partnership between JNJ Managed Services and Guy’s and St. Thomas’ NHS Foundation Trust is designed to optimize the standard of care for orthopedic patients by addressing challenges facing the NHS highlighted in two recent reports by Lord Carter and Professor Briggs, which attempt to address increasing resource challenges in the United Kingdom, partly due to changing demographics that project that by 2030, there will be around 15 million people in the United Kingdom over the age of 65.
As part of the agreement, the orthopedics center at Guy’s Hospital will be expanded and redeveloped, allowing more patients to have access to services. Plans include the development of an additional operating theatre in year one, and eight new state-of-the-art theatres by the end of year three. JNJ will also streamline the supply chain to procure devices, surgical instruments, and implants needed for orthopedic surgery. The Center of Excellence will also provide a hub for education and training, and offer a dedicated space to facilitate leading-edge research.
“The Johnson & Johnson Managed Services partnership will further increase the time that frontline clinicians can focus on patient care and enable us to identify opportunities to improve the supply chain,” said Peter Earnshaw, clinical director of surgery at Guy’s and St. Thomas’. “Through the development of new operating theatres, it will also increase capacity so that we can treat more patients more quickly and will give our clinical teams opportunities to be at the forefront of new developments in orthopedic care.”
“This latest collaboration is testament to our ongoing commitment to Guy’s and St. Thomas’ NHS Foundation Trust, and our commitment to join forces with health care systems to help them address their most pressing challenges,” said Michelle Brennan, Company Group Chair of JNJ Medical Devices Europe, Middle East, and Africa.
Related Links:
Johnson & Johnson
Guy's and St. Thomas' NHS Foundation Trust
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Radiofrequency Generator
GX1
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
- USC Virtual Care Clinic to Employ Avatar Doctors
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
